Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Gustavo R. Rossi"'
Autor:
Lachlan P. Healy, Gustavo R. Rossi, Jai Rautela, Charlotte A. Slade, Nicholas D. Huntington, Ingrid M. Winship, Fernando Souza-Fonseca-Guimaraes
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
We characterized the NK cell phenotype and function in three family members with Hereditary Hemorrhagic Telangiectasia (HHT) due to heterozygous SMAD4 mutations. Loss-of-function mutation in this gene did not induce developmental effects to alter CD5
Externí odkaz:
https://doaj.org/article/2154aa4c373f403e81d16c3c70d82b40
Autor:
Nicholas D. Huntington, Melissa J. Davis, Tania Camilleri, Soroor Hediyeh-Zadeh, Cheng-Yu Lin, Paul A. Beavis, Jennifer H. Gunter, Hae-Young Park, Jumana Yousef, Timothy R. McCulloch, Momeneh Foroutan, Laura F. Dagley, Gustavo R. Rossi, Fernando Souza-Fonseca-Guimaraes
Antibodies targeting “immune checkpoints” have revolutionized cancer therapy by reactivating tumor-resident cytotoxic lymphocytes, primarily CD8+ T cells. Interest in targeting analogous pathways in other cytotoxic lymphocytes is growing. Natural
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ced34a319484d8cb5dcd5f40ed073af
https://doi.org/10.1158/2326-6066.c.6551013
https://doi.org/10.1158/2326-6066.c.6551013
Autor:
Nicholas D. Huntington, Melissa J. Davis, Tania Camilleri, Soroor Hediyeh-Zadeh, Cheng-Yu Lin, Paul A. Beavis, Jennifer H. Gunter, Hae-Young Park, Jumana Yousef, Timothy R. McCulloch, Momeneh Foroutan, Laura F. Dagley, Gustavo R. Rossi, Fernando Souza-Fonseca-Guimaraes
Supplementary Figure from TGFβ and CIS Inhibition Overcomes NK-cell Suppression to Restore Antitumor Immunity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c2f9c0bb28355c8742c0c52c148f592
https://doi.org/10.1158/2326-6066.22545717.v1
https://doi.org/10.1158/2326-6066.22545717.v1
Autor:
Fernando Souza-Fonseca-Guimaraes, Gustavo R. Rossi, Laura F. Dagley, Momeneh Foroutan, Timothy R. McCulloch, Jumana Yousef, Hae-Young Park, Jennifer H. Gunter, Paul A. Beavis, Cheng-Yu Lin, Soroor Hediyeh-Zadeh, Tania Camilleri, Melissa J. Davis, Nicholas D. Huntington
Publikováno v:
Cancer immunology research. 10(9)
Antibodies targeting “immune checkpoints” have revolutionized cancer therapy by reactivating tumor-resident cytotoxic lymphocytes, primarily CD8+ T cells. Interest in targeting analogous pathways in other cytotoxic lymphocytes is growing. Natural